Premier, Inc. (PINC)
NASDAQ: PINC · Real-Time Price · USD
27.10
-0.01 (-0.04%)
At close: Sep 9, 2025, 4:00 PM
27.06
-0.04 (-0.15%)
After-hours: Sep 9, 2025, 5:06 PM EDT
Premier Revenue
In the fiscal year ending June 30, 2025, Premier had annual revenue of $1.01B, down -10.86%. Premier had revenue of $262.86M in the quarter ending June 30, 2025, a decrease of -12.45%.
Revenue (ttm)
$1.01B
Revenue Growth
-10.86%
P/S Ratio
2.44
Revenue / Employee
$375,054
Employees
2,700
Market Cap
2.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.01B | -123.36M | -10.86% |
| Jun 30, 2024 | 1.14B | 40.67M | 3.71% |
| Jun 30, 2023 | 1.10B | -337.56M | -23.56% |
| Jun 30, 2022 | 1.43B | -288.25M | -16.75% |
| Jun 30, 2021 | 1.72B | 421.56M | 32.44% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PINC News
- 6 hours ago - Premier, Inc. Appoints Bruce Radcliff as President of Supply Chain Services - Business Wire
- 5 days ago - Premier, Inc. to Participate in Baird Global Healthcare Conference on September 9, 2025 - Business Wire
- 20 days ago - Premier Analysts Increase Their Forecasts Following Better-Than-Expected Results - Benzinga
- 20 days ago - Top 2 Health Care Stocks That May Fall Off A Cliff In August - Benzinga
- 21 days ago - Premier, Inc. (PINC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results - Business Wire
- 22 days ago - Premier, Inc. Declares Quarterly Cash Dividend - Business Wire
- 4 weeks ago - AIS Healthcare Awarded a Group Purchasing Agreement for 503A Intrathecal Compounded Medications with Premier, Inc. - Business Wire